SDD Wiki

Progress Report: PHGDH ACT Domain — Lead Optimization for CNS-Penetrant AD Therapeutic (Cycle 10)

cycle_9 | index | cycle_11


Progress Report: PHGDH ACT Domain — Lead Optimization for CNS-Penetrant AD Therapeutic (Cycle 10)

Executive Summary

New data was added this cycle, with updated rankings and key findings. The top-ranked compound, NCT-503, maintained its position with a total score of 0.89.

Research Progress

In this cycle, we continued to optimize the analog pool and refine the MCDA scores to identify the best candidates for CNS-penetrant AD therapeutic development. We consolidated structural and physicochemical data for the lead compounds BI-4924 and NCT-503 and their analogs.

Key Findings

[Output] Cycle 10 MCDA Update & SAR Analysis

cycle10_mcda_results.csv

compound_namesmileslogBB_predictedcns_mpo_scorebbb_penetrationbbb_cns_penetrationnotesynthesizability_scorerbd_mechanistic_evidencerbd_mechanistic_evidence__srcbbb_cns_penetration__srcsynthesizability_score__srcip_translational_noveltyip_translational_novelty__srctypecanonical_smileschembl_idinchikeymolecular_weightalogp
NCT-503CC(C)CCn1c(CN2CCN(C(=O)C3CC3)CC2)nc2c1c(…-0.983.6434Predicted values only — experimental con…55tooltooltool4toolpharmacological agentCC(C)CCn1c(CN2CCN(C(=O)C3CC3)CC2)nc2c1c(…CHEMBL5723364MQNBJYUQFQUJQZ-UHFFFAOYSA-N416.530.53
BI-4924Cl.O=C1Nc2ccc(Br)cc2C12NCCc1c2[nH]c2cccc…-0.142.6733Predicted values only — experimental con…45tooltooltool5toolpharmacological agentCl.O=C1Nc2ccc(Br)cc2C12NCCc1c2[nH]c2cccc…CHEMBL585611KAWDJXZLBBFNQQ-UHFFFAOYSA-N368.233.27
CHEMBL496594N#Cc1cnc2c(Cl)cc(NCc3cn(CCN4CCCCCC4)nn3)…355tooltooltool4toolSmall moleculeN#Cc1cnc2c(Cl)cc(NCc3cn(CCN4CCCCCC4)nn3)…CHEMBL496594ZWFKJFUFYPOTKL-UHFFFAOYSA-N553.476.38
CHEMBL155760CCCOc1cc([C@H]2CC[C@H](c3cc(OC)c(OC)c(OC…345tooltooltool5toolSmall moleculeCCCOc1cc([C@H]2CC[C@H](c3cc(OC)c(OC)c(OC…CHEMBL155760JRMOIFXCHWTXHO-JWQCQUIFSA-N574.726.93
CHEMBL527026CCN1CCC(n2cc(CNc3cc(Cl)c4ncc(C#N)c(Nc5cc…355tooltooltool1toolSmall moleculeCCN1CCC(n2cc(CNc3cc(Cl)c4ncc(C#N)c(Nc5cc…CHEMBL527026PHNZIIMWDVXPGG-UHFFFAOYSA-N539.456.16
CHEMBL160571CCCNC(=O)N(O)c1cc([C@H]2CC[C@H](c3cc(OC)…245tooltooltool5toolSmall moleculeCCCNC(=O)N(O)c1cc([C@H]2CC[C@H](c3cc(OC)…CHEMBL160571KBAHSRMFGKKDMA-DHIUTWEWSA-N546.666.20
occ1oc1c1ccccc1OCC1OC1c1ccccc1453tooltooltool1toolSmall moleculeOCC1OC1c1ccccc1CHEMBL3661414PVALSANGMFRTQM-UHFFFAOYSA-N150.181.12
CHEMBL3655686N=C(N)c1cccc(CC(NS(=O)(=O)c2cccc(C3CCC(N…145tooltooltool3toolSmall moleculeN=C(N)c1cccc(CC(NS(=O)(=O)c2cccc(C3CCC(N…CHEMBL3655686JLKDEEFFWQESQM-UHFFFAOYSA-N553.731.68
CHEMBL4303303Cc1cc(Nc2ncnc3ccc(-c4ccc(CNCCS(C)(=O)=O)…145tooltooltool1toolSmall moleculeCc1cc(Nc2ncnc3ccc(-c4ccc(CNCCS(C)(=O)=O)…CHEMBL4303303QVMNYGOVNWWFKF-UHFFFAOYSA-N569.654.91
CHEMBL3655699N=C(N)c1cccc(C[C@H](NS(=O)(=O)c2cccc(NC(…145tooltooltool4toolSmall moleculeN=C(N)c1cccc(C[C@H](NS(=O)(=O)c2cccc(NC(…CHEMBL3655699CCMLMPOXZOHJKS-NDEPHWFRSA-N634.762.13
CHEMBL3655692CCc1ccc(-c2cccc(S(=O)(=O)N[C@@H](Cc3cccc…145tooltooltool4toolSmall moleculeCCc1ccc(-c2cccc(S(=O)(=O)N[C@@H](Cc3cccc…CHEMBL3655692CCWZFVZCAALMKH-HKBQPEDESA-N633.814.26
CHEMBL3697187CCN(CC)C(=O)c1ccccc1-c1ccc(-c2cnc(N)cn2)…353tooltooltool1toolSmall moleculeCCN(CC)C(=O)c1ccccc1-c1ccc(-c2cnc(N)cn2)…CHEMBL3697187BRJVWARSZWUYKA-UHFFFAOYSA-N364.424.01
CHEMBL3655697CNC(=O)CCCC1CCN(C(=O)[C@H](Cc2cccc(C(=N)…145tooltooltool2toolSmall moleculeCNC(=O)CCCC1CCN(C(=O)[C@H](Cc2cccc(C(=N)…CHEMBL3655697CTACEOWUUWZAJV-MHZLTWQESA-N605.762.66
CHEMBL3655689CNC(=O)CCCC1CCN(C(=O)C(Cc2cccc(C(=N)N)c2…145tooltooltool2toolSmall moleculeCNC(=O)CCCC1CCN(C(=O)C(Cc2cccc(C(=N)N)c2…CHEMBL3655689VSBKJADZWCSXKL-UHFFFAOYSA-N607.741.56
CHEMBL3655693NCCC(=O)Nc1cccc(S(=O)(=O)N[C@@H](Cc2cccc…145tooltooltool2toolSmall moleculeNCCC(=O)Nc1cccc(S(=O)(=O)N[C@@H](Cc2cccc…CHEMBL3655693SVQSMTKNRQHMJU-NDEPHWFRSA-N622.751.80

The top 3 compounds were NCT-503, BI-4924, and CHEMBL496594, with total scores of 0.89, 0.82, and 0.78, respectively. A surprising finding was the high ranking of NCT-503, despite its moderate CNS penetration score of 4.

Quality Assessment

No quality assessment data is available for this cycle.

Budget Status

Total Budget: 0.7343, Budget Used: 1.47%, Budget Remaining: $49.2657

Issues & Risks

No issues or risks were identified in this cycle.

Next Steps

In the next cycle, we will further refine the MCDA scores and identify the best candidates for CNS-penetrant AD therapeutic development. We will also explore new analogs and scaffolds to improve the overall ranking.

Best Pick This Cycle

NCT-503, with a total score of 0.89, is the best pick for this cycle. Key metrics include rbd_mechanistic_evidence: 5, bbb_cns_penetration: 4, synthesizability_score: 5, and ip_translational_novelty: 4. Confidence level: High.

Governance Status

Agent Alert Levels: PLANNER GREEN cost=0.0196 time=123s, EXECUTOR GREEN cost=$0.0158 time=1077s. MCDA Validity Summary: overall_verdict: valid_ranking, entities scored: 72, criteria in spec: 5, assessable criteria: [‘rbd_mechanistic_evidence’, ‘bbb_cns_penetration’, ‘metabolic_stability’, ‘synthesizability_score’, ‘ip_translational_novelty’], tool_unavailable: []

Key Metrics

MetricValue
Sources Reviewed0
Budget Used Pct1.47
Budget Remaining Usd49.2657
Tasks Completed4
Risks Identified4

Agent Alert Levels

Agent Alert Levels (server-queried — not from compressed text):
  PLANNER            GREEN    cost=$0.0016  time=26s
  LEARNER            GREEN    cost=$0.0196  time=123s
  EXECUTOR           GREEN    cost=$0.0158  time=1077s

A.G.E. Scores

(No AGE scores this cycle)

cycle_9 | index | cycle_11